AGENUS INC Total Assets
AGENUS INC (AGEN) had Total Assets of $172.69 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-07
- 2026-06-30: Assets $172.69M.
- 2026-03-31: Assets $186.46M.
- 2025-12-31: Assets $226.80M.
- 2025-09-30: Assets $233.89M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $172.69M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $186.46M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $226.80M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $233.89M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $185.22M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $200.20M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $226.27M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $238.48M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $292.42M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $256.56M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $313.91M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $335.47M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $383.59M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $412.85M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $413.56M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $429.02M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $456.17M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $441.31M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $465.96M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $437.64M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $192.30M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $234.91M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $214.51M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $204.48M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $185.78M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $180.06M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $155.34M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $174.81M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $206.71M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $245.93M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $136.40M 10-K · filed 2020-03-16 | $136.40M 10-K · filed 2019-03-18 |
| 2018-09-30 | $130.48M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $131.94M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $130.82M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $138.40M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $149.27M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $176.49M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $203.27M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $156.99M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $174.84M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $196.45M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $221.14M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $242.23M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $242.61M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $180.11M 10-Q · filed 2015-08-03 | |
| 2015-03-31 | $117.32M 10-Q · filed 2015-05-01 | |
| 2014-12-31 | $74.53M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $87.63M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $100.19M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $108.30M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $34.84M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $37.67M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $21.37M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $25.13M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $29.09M 10-K · filed 2014-03-07 | |
| 2012-09-30 | $32.22M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $33.27M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $33.21M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $19.81M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $24.37M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $22.23M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $30.91M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |